Literature DB >> 27323783

Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Ralf G Rempe1, Anika M S Hartz2, Björn Bauer3.   

Abstract

Matrix metalloproteinases are versatile endopeptidases with many different functions in the body in health and disease. In the brain, matrix metalloproteinases are critical for tissue formation, neuronal network remodeling, and blood-brain barrier integrity. Many reviews have been published on matrix metalloproteinases before, most of which focus on the two best studied matrix metalloproteinases, the gelatinases MMP-2 and MMP-9, and their role in one or two diseases. In this review, we provide a broad overview of the role various matrix metalloproteinases play in brain disorders. We summarize and review current knowledge and understanding of matrix metalloproteinases in the brain and at the blood-brain barrier in neuroinflammation, multiple sclerosis, cerebral aneurysms, stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and brain cancer. We discuss the detrimental effects matrix metalloproteinases can have in these conditions, contributing to blood-brain barrier leakage, neuroinflammation, neurotoxicity, demyelination, tumor angiogenesis, and cancer metastasis. We also discuss the beneficial role matrix metalloproteinases can play in neuroprotection and anti-inflammation. Finally, we address matrix metalloproteinases as potential therapeutic targets. Together, in this comprehensive review, we summarize current understanding and knowledge of matrix metalloproteinases in the brain and at the blood-brain barrier in brain disorders.
© The Author(s) 2016.

Entities:  

Keywords:  Alzheimer’s; Blood–brain barrier; Parkinson’s disease; epilepsy; inflammation; intracranial aneurysm; multiple sclerosis; neurodegeneration; stroke

Mesh:

Substances:

Year:  2016        PMID: 27323783      PMCID: PMC5012524          DOI: 10.1177/0271678X16655551

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  308 in total

Review 1.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

Authors:  D R Groothuis
Journal:  Neuro Oncol       Date:  2000-01       Impact factor: 12.300

2.  Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts.

Authors:  Masanori Nishikawa; Yoshinori Yamaguchi; Kazusada Yoshitake; Yukikazu Saeki
Journal:  J Periodontal Res       Date:  2002-06       Impact factor: 4.419

Review 3.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

4.  FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.

Authors:  Anke Van der Perren; Francesca Macchi; Jaan Toelen; Marianne S Carlon; Michael Maris; Henriette de Loor; Dirk R J Kuypers; Rik Gijsbers; Chris Van den Haute; Zeger Debyser; Veerle Baekelandt
Journal:  Neurobiol Aging       Date:  2015-01-21       Impact factor: 4.673

5.  Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Authors:  Ping Yan; Xiaoyan Hu; Haowei Song; Kejie Yin; Randall J Bateman; John R Cirrito; Qingli Xiao; Fong F Hsu; John W Turk; Jan Xu; Chung Y Hsu; David M Holtzman; Jin-Moo Lee
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

6.  Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Authors:  John R Goffin; Ian C Anderson; Jeffrey G Supko; Joseph Paul Eder; Geoffrey I Shapiro; Thomas J Lynch; Margaret Shipp; Bruce E Johnson; Arthur T Skarin
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

7.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

Authors:  Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla
Journal:  Brain Res       Date:  2010-03-01       Impact factor: 3.252

8.  CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.

Authors:  Naoko Suenaga; Hidetoshi Mori; Yoshifumi Itoh; Motoharu Seiki
Journal:  Oncogene       Date:  2005-01-27       Impact factor: 9.867

9.  The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.

Authors:  R K Zabad; L M Metz; T R Todoruk; Y Zhang; J R Mitchell; M Yeung; D G Patry; R B Bell; V W Yong
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

Review 10.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

View more
  158 in total

1.  Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.

Authors:  Binbin Zheng; Yanjun Jin; Shuang Mi; Wei Xu; Xiangdong Yang; Zhenghua Hong; Zhangfu Wang
Journal:  Neurochem Res       Date:  2021-06-04       Impact factor: 3.996

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

Review 3.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  From blast to bench: A translational mini-review of posttraumatic headache.

Authors:  Laura S Moye; Amynah A Pradhan
Journal:  J Neurosci Res       Date:  2017-02-02       Impact factor: 4.164

Review 5.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

Review 6.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

7.  Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease.

Authors:  Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Smita Zaheer; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Sudhanshu Raikwar; Raghav Govindarajan; Shankar Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-26       Impact factor: 4.147

8.  NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.

Authors:  Chun-Chun Wei; Yuan-Yuan Kong; Xia Hua; Guo-Qiang Li; Si-Li Zheng; Ming-He Cheng; Pei Wang; Chao-Yu Miao
Journal:  Br J Pharmacol       Date:  2017-09-06       Impact factor: 8.739

Review 9.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

Review 10.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.